Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT

Martin Schmidt-Hieber, Dan Engelhard, Andrew Ullmann, Per Ljungman, Johan Maertens, Rodrigo Martino, Montserrat Rovira, Peter J. Shaw, Christine Robin, Maura Faraci, Jenny Byrne, Kerstin Schäfer-Eckart, Hermann Einsele, Edgar Faber, Luigi Rigacci, Riccardo Saccardi, Aitana Balaguer-Rosello, Cecilia Isaksson, Maximilian Christopeit, Gloria TridelloJunfeng Wang, Nina Knelange, Malgorzata Mikulska, Simone Cesaro, Jan Styczynski

Research output: Contribution to journalArticle

Abstract

We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36%) were infections. Proven or probable infections were documented in 34 patients and included fungi (n = 10, 29%), viruses (n = 12, 35%), Toxoplasma spp. (n = 9, 27%) and bacteria (n = 3, 9%). Non-infectious neurological disorders (n = 105, 64%) frequently encompassed metabolic/drug-induced abnormalities (n = 28, 27%) or cerebral vascular events (n = 22, 21%). Median onset times were later for infectious (day + 101) vs non-infectious neurological disorders (day + 50, p = 0.009). An unremarkable cranial CT scan was found in 33% of infection episodes. Absence of cerebrospinal fluid pleocytosis despite a normal or increased peripheral blood white blood cell count occurred in 26% of infections. Day-30 mortality rates were significantly higher for fungal (87%) vs non-fungal infections (40%, p < 0.001). Significantly higher mortality rates were also documented for cerebral vascular events than for other non-infectious disorders (86% vs 34%, p < 0.001). Our prospective study shows that diagnostic findings in CNS infections might differ between hematopoietic stem cell transplant recipients and immunocompetent hosts. Special awareness and timely initiation of adequate diagnostics are crucial to improve the prognosis of these patients.

Original languageEnglish
JournalJournal of Neurology
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Hematopoietic Stem Cell Transplantation
Central Nervous System Diseases
Communicable Diseases
Prospective Studies
Infection
Nervous System Diseases
Drug-Induced Abnormalities
Blood Vessels
Central Nervous System Infections
Mortality
Leukocytosis
Toxoplasma
Hematopoietic Stem Cells
Leukocyte Count
Cerebrospinal Fluid
Fungi
Viruses
Bacteria
Transplants

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Central nervous system disorders after hematopoietic stem cell transplantation : a prospective study of the Infectious Diseases Working Party of EBMT. / Schmidt-Hieber, Martin; Engelhard, Dan; Ullmann, Andrew; Ljungman, Per; Maertens, Johan; Martino, Rodrigo; Rovira, Montserrat; Shaw, Peter J.; Robin, Christine; Faraci, Maura; Byrne, Jenny; Schäfer-Eckart, Kerstin; Einsele, Hermann; Faber, Edgar; Rigacci, Luigi; Saccardi, Riccardo; Balaguer-Rosello, Aitana; Isaksson, Cecilia; Christopeit, Maximilian; Tridello, Gloria; Wang, Junfeng; Knelange, Nina; Mikulska, Malgorzata; Cesaro, Simone; Styczynski, Jan.

In: Journal of Neurology, 01.01.2019.

Research output: Contribution to journalArticle

Schmidt-Hieber, M, Engelhard, D, Ullmann, A, Ljungman, P, Maertens, J, Martino, R, Rovira, M, Shaw, PJ, Robin, C, Faraci, M, Byrne, J, Schäfer-Eckart, K, Einsele, H, Faber, E, Rigacci, L, Saccardi, R, Balaguer-Rosello, A, Isaksson, C, Christopeit, M, Tridello, G, Wang, J, Knelange, N, Mikulska, M, Cesaro, S & Styczynski, J 2019, 'Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT', Journal of Neurology. https://doi.org/10.1007/s00415-019-09578-5
Schmidt-Hieber, Martin ; Engelhard, Dan ; Ullmann, Andrew ; Ljungman, Per ; Maertens, Johan ; Martino, Rodrigo ; Rovira, Montserrat ; Shaw, Peter J. ; Robin, Christine ; Faraci, Maura ; Byrne, Jenny ; Schäfer-Eckart, Kerstin ; Einsele, Hermann ; Faber, Edgar ; Rigacci, Luigi ; Saccardi, Riccardo ; Balaguer-Rosello, Aitana ; Isaksson, Cecilia ; Christopeit, Maximilian ; Tridello, Gloria ; Wang, Junfeng ; Knelange, Nina ; Mikulska, Malgorzata ; Cesaro, Simone ; Styczynski, Jan. / Central nervous system disorders after hematopoietic stem cell transplantation : a prospective study of the Infectious Diseases Working Party of EBMT. In: Journal of Neurology. 2019.
@article{d8d7ad02b6db400c935997b3ce0df302,
title = "Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT",
abstract = "We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36{\%}) were infections. Proven or probable infections were documented in 34 patients and included fungi (n = 10, 29{\%}), viruses (n = 12, 35{\%}), Toxoplasma spp. (n = 9, 27{\%}) and bacteria (n = 3, 9{\%}). Non-infectious neurological disorders (n = 105, 64{\%}) frequently encompassed metabolic/drug-induced abnormalities (n = 28, 27{\%}) or cerebral vascular events (n = 22, 21{\%}). Median onset times were later for infectious (day + 101) vs non-infectious neurological disorders (day + 50, p = 0.009). An unremarkable cranial CT scan was found in 33{\%} of infection episodes. Absence of cerebrospinal fluid pleocytosis despite a normal or increased peripheral blood white blood cell count occurred in 26{\%} of infections. Day-30 mortality rates were significantly higher for fungal (87{\%}) vs non-fungal infections (40{\%}, p < 0.001). Significantly higher mortality rates were also documented for cerebral vascular events than for other non-infectious disorders (86{\%} vs 34{\%}, p < 0.001). Our prospective study shows that diagnostic findings in CNS infections might differ between hematopoietic stem cell transplant recipients and immunocompetent hosts. Special awareness and timely initiation of adequate diagnostics are crucial to improve the prognosis of these patients.",
author = "Martin Schmidt-Hieber and Dan Engelhard and Andrew Ullmann and Per Ljungman and Johan Maertens and Rodrigo Martino and Montserrat Rovira and Shaw, {Peter J.} and Christine Robin and Maura Faraci and Jenny Byrne and Kerstin Sch{\"a}fer-Eckart and Hermann Einsele and Edgar Faber and Luigi Rigacci and Riccardo Saccardi and Aitana Balaguer-Rosello and Cecilia Isaksson and Maximilian Christopeit and Gloria Tridello and Junfeng Wang and Nina Knelange and Malgorzata Mikulska and Simone Cesaro and Jan Styczynski",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00415-019-09578-5",
language = "English",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",

}

TY - JOUR

T1 - Central nervous system disorders after hematopoietic stem cell transplantation

T2 - a prospective study of the Infectious Diseases Working Party of EBMT

AU - Schmidt-Hieber, Martin

AU - Engelhard, Dan

AU - Ullmann, Andrew

AU - Ljungman, Per

AU - Maertens, Johan

AU - Martino, Rodrigo

AU - Rovira, Montserrat

AU - Shaw, Peter J.

AU - Robin, Christine

AU - Faraci, Maura

AU - Byrne, Jenny

AU - Schäfer-Eckart, Kerstin

AU - Einsele, Hermann

AU - Faber, Edgar

AU - Rigacci, Luigi

AU - Saccardi, Riccardo

AU - Balaguer-Rosello, Aitana

AU - Isaksson, Cecilia

AU - Christopeit, Maximilian

AU - Tridello, Gloria

AU - Wang, Junfeng

AU - Knelange, Nina

AU - Mikulska, Malgorzata

AU - Cesaro, Simone

AU - Styczynski, Jan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36%) were infections. Proven or probable infections were documented in 34 patients and included fungi (n = 10, 29%), viruses (n = 12, 35%), Toxoplasma spp. (n = 9, 27%) and bacteria (n = 3, 9%). Non-infectious neurological disorders (n = 105, 64%) frequently encompassed metabolic/drug-induced abnormalities (n = 28, 27%) or cerebral vascular events (n = 22, 21%). Median onset times were later for infectious (day + 101) vs non-infectious neurological disorders (day + 50, p = 0.009). An unremarkable cranial CT scan was found in 33% of infection episodes. Absence of cerebrospinal fluid pleocytosis despite a normal or increased peripheral blood white blood cell count occurred in 26% of infections. Day-30 mortality rates were significantly higher for fungal (87%) vs non-fungal infections (40%, p < 0.001). Significantly higher mortality rates were also documented for cerebral vascular events than for other non-infectious disorders (86% vs 34%, p < 0.001). Our prospective study shows that diagnostic findings in CNS infections might differ between hematopoietic stem cell transplant recipients and immunocompetent hosts. Special awareness and timely initiation of adequate diagnostics are crucial to improve the prognosis of these patients.

AB - We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36%) were infections. Proven or probable infections were documented in 34 patients and included fungi (n = 10, 29%), viruses (n = 12, 35%), Toxoplasma spp. (n = 9, 27%) and bacteria (n = 3, 9%). Non-infectious neurological disorders (n = 105, 64%) frequently encompassed metabolic/drug-induced abnormalities (n = 28, 27%) or cerebral vascular events (n = 22, 21%). Median onset times were later for infectious (day + 101) vs non-infectious neurological disorders (day + 50, p = 0.009). An unremarkable cranial CT scan was found in 33% of infection episodes. Absence of cerebrospinal fluid pleocytosis despite a normal or increased peripheral blood white blood cell count occurred in 26% of infections. Day-30 mortality rates were significantly higher for fungal (87%) vs non-fungal infections (40%, p < 0.001). Significantly higher mortality rates were also documented for cerebral vascular events than for other non-infectious disorders (86% vs 34%, p < 0.001). Our prospective study shows that diagnostic findings in CNS infections might differ between hematopoietic stem cell transplant recipients and immunocompetent hosts. Special awareness and timely initiation of adequate diagnostics are crucial to improve the prognosis of these patients.

UR - http://www.scopus.com/inward/record.url?scp=85074665498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074665498&partnerID=8YFLogxK

U2 - 10.1007/s00415-019-09578-5

DO - 10.1007/s00415-019-09578-5

M3 - Article

C2 - 31664549

AN - SCOPUS:85074665498

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

ER -